Exploration into conolidine has triggered discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 seems to be by far the most wanted goal for conolidine, which also disregards another four classical opioid receptors(three). There exists interest in employing conolidine being a pain-reliever based on evidence from https://devincawmc.jiliblog.com/94600323/the-basic-principles-of-alternative-natural-pain-relief-to-replace-traditional-painkillers